business / news / / Deccan Chronicle
Novo Nordisk A/S will integrate OpenAI’s artificial intelligence across the company.
Novo Nordisk will fully integrate OpenAI's AI across all company operations by year-end.
KEY POINTS
- The partnership extends beyond ChatGPT access, involving pilot programs in R&D, manufacturing, and commercial units.
- Novo aims to use OpenAI's AI to accelerate drug target identification and clinical trial design.
- CEO Mike Doustdar has eliminated about 9,000 jobs to foster a faster, performance-driven culture.
COMPANIES
Summarized by Newsio from Deccan Chronicle. How we summarize →